Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesEffects of low-dose intranasal (S)-ketamine in patients with neuropathic pain
European Journal of Pain, 09/08/09
Huge V et al. – Intranasal administration of low dose (S)–ketamine rapidly induces adequate plasma concentrations of (S)–ketamine and subsequently of its metabolite (S)–norketamine. The time course of analgesia correlated with plasma concentrations.
Related Articles
Neuropathic pain: Peripheral and central mechanisms
European Journal of Pain, 11/12/09
Relevance Score: 70%
Targeting the NMDA Receptor Subunit NR2B for the Treatment of Neuropathic Pain
Neurotherapeutics, 10/05/09
Relevance Score: 70%
The pharmacological treatment of neuropathic pain
European Journal of Pain, 11/12/09
Relevance Score: 69%
Characterization of chronic pain patients in German pain centers. Core data from more than 10,000 patients
Schmerz, 10/06/09
Relevance Score: 69%
Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
Neurotherapeutics, 10/05/09
Relevance Score: 69%
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Intraspinal techniques for pain management in cancer patients: a systematic review
Supportive Care in Cancer, 12/04/09
Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients
Scandinavian Journal of Pain, 12/04/09
The Roles of Pharmacists in Pain Management
Journal Of Pain & Palliative Care Pharmacotherapy, 12/03/09
Sponsor
Article Search
Sponsor